BackIntelligent Bio Solutions Overview

Intelligent Bio Solutions Net Tangible Assets

Track Intelligent Bio Solutions's net tangible assets ($8.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$8.75M

Peer average

Loading

Intelligent Bio Solutions Net Tangible Assets History

Loading

Intelligent Bio Solutions vs. peers: Net Tangible Assets Comparison

Loading

Intelligent Bio Solutions Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Intelligent Bio Solutions (GBS) FAQ

As of the most recent data (March 2026), GBS shows a net tangible assets of $8.8M. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GBS's net tangible assets is now $8.8M (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Intelligent Bio Solutions is outperforming or lagging.

Tracking GBS's net tangible assets over time shows whether Intelligent Bio Solutions is scaling, shrinking, or reshaping that part of the business. The current reading is $8.8M In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net tangible assets page, Stockcircle has Intelligent Bio Solutions's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net tangible assets (currently $8.8M) with ownership activity and broader fundamentals.

Intelligent Bio Solutions's net tangible assets is $8.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.